The evolving landscape of <scp>COVID</scp>‐19 and <scp>post‐COVID</scp> condition in patients with chronic lymphocytic leukemia: A study by <scp>ERIC</scp>, the <scp>European</scp> research initiative on <scp>CLL</scp>Andrea Visentin, Gilad Itchaki, Thomas Chatzikonstantinou et al.|American Journal of Hematology|2023Cited by 21
Improving Quality of Life Based on Electronic Patient Reported Outcomes in Patients with CLL and MDS: The Mypal StudyThomas Chatzikonstantinou, Lydia Scarfò, Maria Vasilopoulou et al.|Blood|2024Cited by 0
Survival Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Treated in the Chemoimmunotherapy Vs BTK Inhibitor (BTKi) Eras: A European Research Initiative on CLL (ERIC) StudyT C, David Oscier, Sotiria Besikli‐Dimou et al.|Blood|2024Cited by 0
Assessing an eHealth Intervention on Quality of Life in Patients With Chronic Lymphocytic Leukemia and Myelodysplastic Syndromes: The MyPal Randomized Controlled TrialThomas Chatzikonstantinou, Maria Vasilopoulou, Dimitrios Kyrou et al.|JCO Oncology Practice|2025Cited by 0